Clinical Trial Update: One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer [NA]

View source ↗

Summary

A clinical trial evaluating one week versus three weeks of adjuvant radiotherapy in breast cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Tata Medical Center | Conditions: Breast Cancer Female | NA | Status: RECRUITING